Jean-François Rossi, MD; Nathalie Fegueux, MD; Brigitte Calvet, MD; Wandrille Godefroy, MD
This content is PDF only. Please click on the PDF icon to access.
To the Editor: We read with interest the article on angioimmunoblastic lymphadenopathy with dysproteinemia (AILD) (1). This disease is characterized by a clonal expansion of both B and T lymphocytes with expression of a particular histologic pattern. Treatment usually consists of corticosteroids or alkylating agents, resulting in a poor prognosis. Little is known about the effect of alpha-interferon in such a disease. Only one patient has been successfully treated with alpha-interferon (2). Alpha-interferon has been shown to be an effective treatment in some T-cell lymphopathies, such as epidermotropic T-cell lymphomas (3). We report the case of a patient with AILD
Rossi J, Fegueux N, Calvet B, et al. Alpha-Interferon in Angioimmunoblastic Lymphadenopathy. Ann Intern Med. 1988;109:512–513. doi: 10.7326/0003-4819-109-6-512
Download citation file:
Published: Ann Intern Med. 1988;109(6):512-513.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use